Drug Metabolism and Pharmacokinetics 2012-01-01

ABCG2 modulates chlorothiazide permeability--in vitro-characterization of its interactions.

Erzsébet Beéry, Zsuzsanna Rajnai, Tibor Abonyi, Ildikó Makai, Száva Bánsághi, Franciska Erdő, István Sziráki, Krisztina Herédi-Szabó, Emese Kis, Márton Jani, János Márki-Zay, Gábor K Tóth, Péter Krajcsi

Index: Drug Metab. Pharmacokinet. 27(3) , 349-53, (2012)

Full Text: HTML

Abstract

We are showing that chlorothiazide, a diuretic, is an ABCG2 substrate. It is a Biopharmaceutics Classification System/Biopharmaceutics Drug Distribution and Classification System (BCS/BDDCS) Class IV drug with low bioavailability. Therefore, we tested if chlorothiazide interacts with major apically located intestinal efflux transporters. Our data show that chlorothiazide is transported by ABCG2 with a Km value of 334.6 µM and does not interact with ABCB1 or ABCC2. The chlorothiazide-ABCG2 interaction results in a vectorial transport in MDCKII-BCRP and Caco-2 cells with efflux ratios of 36 and 8.1 respectively. Inhibition of ABCG2 in Caco-2 cells reduced the efflux ratio to 1.4, suggesting that ABCG2 plays a role in limiting chlorothiazide bioavailability in humans.

Related Compounds

  • Estrone sulfate so...
  • Chlorothiazide
  • Estrone sulfate po...

Related Articles:

Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.

2013-01-01

[J. Pharm. Sci. 102(1) , 280-8, (2013)]

Quantitative transporter proteomics by liquid chromatography with tandem mass spectrometry: addressing methodologic issues of plasma membrane isolation and expression-activity relationship.

2015-02-01

[Drug Metab. Dispos. 43(2) , 284-8, (2015)]

Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.

2014-10-01

[J. Clin. Oncol. 32(28) , 3111-7, (2014)]

Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins.

2012-08-30

[Eur. J. Pharm. Sci. 47(1) , 244-55, (2012)]

Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.

2014-04-01

[Eur. J. Cancer 50(6) , 1055-64, (2014)]

More Articles...